Rethinking Wellness cover image

The Dangers of Diet Drugs: Behind the GLP-1 Weight-Loss Hype with Ragen Chastain

Rethinking Wellness

00:00

Risks and Deceptive Practices in Weight Loss Drug Industry

The chapter explores the serious risks and potential side effects associated with weight loss drugs, revealing the lack of long-term safety data and the skewed risk-benefit analysis in the industry. It exposes the aggressive marketing tactics of pharmaceutical companies like Novo Nordisk and Eli Lilly, influencing media, funding campaigns, and lack of disclosure on financial ties with experts. Additionally, the unethical practices of a pharmaceutical company in promoting their weight-loss drug in the UK and the US are scrutinized, showcasing similarities with Purdue Pharma's notorious tactics.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app